Learn how to use Level 2 market data for investment research with Moomoo! Understand bid/ask prices, market makers, and ...

Near-term risks persist amid market optimism. Focus on high-quality stocks trading below fair value to strengthen your ...

International Flavors & Fragrances is a smart buy after its 60% drop. Management expects modest 1-4% revenue growth in 2025.

Palantir's revenue and margins are surging, and management lifted full-year guidance again. Other high-performing peers with strong growth are trading at significantly lower valuations than Palantir.

Palantir's software is being used by government and commercial clients alike. Palantir continues to exceed its own expectations. The stock has an expensive price tag, which could limit further upside.

India's rail safety revolution is unfolding with Kavach at its core— and a few little-known companies are quietly turning ...

FDA clearance is a vital milestone for ASX medical device companies, opening access to the US market while navigating the regulatory process.

Investors were excited about the company's prospects following its 2014 IPO. Enthusiasm for GoPro's wares has waned as competitive pressures have grown. A recent initiative offering to pay users for ...

Rebecca Maclean, fund manager at Dunedin Income Growth Investment Trust on gold, the stock she'd buy for the next 10 years, ...